Global Dendritic Cell Cancer Vaccine Market Research Report 2019


    Table of Contents

      Executive Summary

        1 Dendritic Cell Cancer Vaccine Market Overview

        • 1.1 Product Overview and Scope of Dendritic Cell Cancer Vaccine
        • 1.2 Dendritic Cell Cancer Vaccine Segment by Type
          • 1.2.1 Global Dendritic Cell Cancer Vaccine Production Growth Rate Comparison by Type (2014-2025)
          • 1.2.2 CreaVax
          • 1.2.3 Sipuleucel-T (Provenge)
          • 1.2.4 Others
        • 1.3 Dendritic Cell Cancer Vaccine Segment by Application
          • 1.3.1 Dendritic Cell Cancer Vaccine Consumption Comparison by Application (2014-2025)
          • 1.3.2 Pediatrics
          • 1.3.3 Adults
        • 1.4 Global Dendritic Cell Cancer Vaccine Market by Region
          • 1.4.1 Global Dendritic Cell Cancer Vaccine Market Size Region
          • 1.4.2 North America Status and Prospect (2014-2025)
          • 1.4.3 Europe Status and Prospect (2014-2025)
          • 1.4.4 China Status and Prospect (2014-2025)
          • 1.4.5 Japan Status and Prospect (2014-2025)
        • 1.5 Global Dendritic Cell Cancer Vaccine Market Size
          • 1.5.1 Global Dendritic Cell Cancer Vaccine Revenue (2014-2025)
          • 1.5.2 Global Dendritic Cell Cancer Vaccine Production (2014-2025)

        2 Global Dendritic Cell Cancer Vaccine Market Competition by Manufacturers

        • 2.1 Global Dendritic Cell Cancer Vaccine Production Market Share by Manufacturers (2014-2019)
        • 2.2 Global Dendritic Cell Cancer Vaccine Revenue Share by Manufacturers (2014-2019)
        • 2.3 Global Dendritic Cell Cancer Vaccine Average Price by Manufacturers (2014-2019)
        • 2.4 Manufacturers Dendritic Cell Cancer Vaccine Production Sites, Area Served, Product Types
        • 2.5 Dendritic Cell Cancer Vaccine Market Competitive Situation and Trends
          • 2.5.1 Dendritic Cell Cancer Vaccine Market Concentration Rate
          • 2.5.2 Dendritic Cell Cancer Vaccine Market Share of Top 3 and Top 5 Manufacturers
          • 2.5.3 Mergers & Acquisitions, Expansion

        3 Global Dendritic Cell Cancer Vaccine Production Market Share by Regions

        • 3.1 Global Dendritic Cell Cancer Vaccine Production Market Share by Regions
        • 3.2 Global Dendritic Cell Cancer Vaccine Revenue Market Share by Regions (2014-2019)
        • 3.3 Global Dendritic Cell Cancer Vaccine Production, Revenue, Price and Gross Margin (2014-2019)
        • 3.4 North America Dendritic Cell Cancer Vaccine Production
          • 3.4.1 North America Dendritic Cell Cancer Vaccine Production Growth Rate (2014-2019)
          • 3.4.2 North America Dendritic Cell Cancer Vaccine Production, Revenue, Price and Gross Margin (2014-2019)
        • 3.5 Europe Dendritic Cell Cancer Vaccine Production
          • 3.5.1 Europe Dendritic Cell Cancer Vaccine Production Growth Rate (2014-2019)
          • 3.5.2 Europe Dendritic Cell Cancer Vaccine Production, Revenue, Price and Gross Margin (2014-2019)
        • 3.6 China Dendritic Cell Cancer Vaccine Production (2014-2019)
          • 3.6.1 China Dendritic Cell Cancer Vaccine Production Growth Rate (2014-2019)
          • 3.6.2 China Dendritic Cell Cancer Vaccine Production, Revenue, Price and Gross Margin (2014-2019)
        • 3.7 Japan Dendritic Cell Cancer Vaccine Production (2014-2019)
          • 3.7.1 Japan Dendritic Cell Cancer Vaccine Production Growth Rate (2014-2019)
          • 3.7.2 Japan Dendritic Cell Cancer Vaccine Production, Revenue, Price and Gross Margin (2014-2019)

        4 Global Dendritic Cell Cancer Vaccine Consumption by Regions

        • 4.1 Global Dendritic Cell Cancer Vaccine Consumption by Regions
        • 4.2 North America Dendritic Cell Cancer Vaccine Consumption (2014-2019)
        • 4.3 Europe Dendritic Cell Cancer Vaccine Consumption (2014-2019)
        • 4.4 China Dendritic Cell Cancer Vaccine Consumption (2014-2019)
        • 4.5 Japan Dendritic Cell Cancer Vaccine Consumption (2014-2019)

        5 Global Dendritic Cell Cancer Vaccine Production, Revenue, Price Trend by Type

        • 5.1 Global Dendritic Cell Cancer Vaccine Production Market Share by Type (2014-2019)
        • 5.2 Global Dendritic Cell Cancer Vaccine Revenue Market Share by Type (2014-2019)
        • 5.3 Global Dendritic Cell Cancer Vaccine Price by Type (2014-2019)
        • 5.4 Global Dendritic Cell Cancer Vaccine Production Growth by Type (2014-2019)

        6 Global Dendritic Cell Cancer Vaccine Market Analysis by Applications

        • 6.1 Global Dendritic Cell Cancer Vaccine Consumption Market Share by Application (2014-2019)
        • 6.2 Global Dendritic Cell Cancer Vaccine Consumption Growth Rate by Application (2014-2019)

        7 Company Profiles and Key Figures in Dendritic Cell Cancer Vaccine Business

        • 7.1 Medigene
          • 7.1.1 Medigene Dendritic Cell Cancer Vaccine Production Sites and Area Served
          • 7.1.2 Dendritic Cell Cancer Vaccine Product Introduction, Application and Specification
          • 7.1.3 Medigene Dendritic Cell Cancer Vaccine Production, Revenue, Price and Gross Margin (2014-2019)
          • 7.1.4 Main Business and Markets Served
        • 7.2 Activarti
          • 7.2.1 Activarti Dendritic Cell Cancer Vaccine Production Sites and Area Served
          • 7.2.2 Dendritic Cell Cancer Vaccine Product Introduction, Application and Specification
          • 7.2.3 Activarti Dendritic Cell Cancer Vaccine Production, Revenue, Price and Gross Margin (2014-2019)
          • 7.2.4 Main Business and Markets Served
        • 7.3 Argos Therapeutics
          • 7.3.1 Argos Therapeutics Dendritic Cell Cancer Vaccine Production Sites and Area Served
          • 7.3.2 Dendritic Cell Cancer Vaccine Product Introduction, Application and Specification
          • 7.3.3 Argos Therapeutics Dendritic Cell Cancer Vaccine Production, Revenue, Price and Gross Margin (2014-2019)
          • 7.3.4 Main Business and Markets Served
        • 7.4 Batavia Bioservices
          • 7.4.1 Batavia Bioservices Dendritic Cell Cancer Vaccine Production Sites and Area Served
          • 7.4.2 Dendritic Cell Cancer Vaccine Product Introduction, Application and Specification
          • 7.4.3 Batavia Bioservices Dendritic Cell Cancer Vaccine Production, Revenue, Price and Gross Margin (2014-2019)
          • 7.4.4 Main Business and Markets Served
        • 7.5 Bellicum Pharmaceuticals
          • 7.5.1 Bellicum Pharmaceuticals Dendritic Cell Cancer Vaccine Production Sites and Area Served
          • 7.5.2 Dendritic Cell Cancer Vaccine Product Introduction, Application and Specification
          • 7.5.3 Bellicum Pharmaceuticals Dendritic Cell Cancer Vaccine Production, Revenue, Price and Gross Margin (2014-2019)
          • 7.5.4 Main Business and Markets Served
        • 7.6 Creagene
          • 7.6.1 Creagene Dendritic Cell Cancer Vaccine Production Sites and Area Served
          • 7.6.2 Dendritic Cell Cancer Vaccine Product Introduction, Application and Specification
          • 7.6.3 Creagene Dendritic Cell Cancer Vaccine Production, Revenue, Price and Gross Margin (2014-2019)
          • 7.6.4 Main Business and Markets Served
        • 7.7 DanDrit Biotech
          • 7.7.1 DanDrit Biotech Dendritic Cell Cancer Vaccine Production Sites and Area Served
          • 7.7.2 Dendritic Cell Cancer Vaccine Product Introduction, Application and Specification
          • 7.7.3 DanDrit Biotech Dendritic Cell Cancer Vaccine Production, Revenue, Price and Gross Margin (2014-2019)
          • 7.7.4 Main Business and Markets Served
        • 7.8 DCPrime
          • 7.8.1 DCPrime Dendritic Cell Cancer Vaccine Production Sites and Area Served
          • 7.8.2 Dendritic Cell Cancer Vaccine Product Introduction, Application and Specification
          • 7.8.3 DCPrime Dendritic Cell Cancer Vaccine Production, Revenue, Price and Gross Margin (2014-2019)
          • 7.8.4 Main Business and Markets Served
        • 7.9 Sanpower Corporation (Dendreon)
          • 7.9.1 Sanpower Corporation (Dendreon) Dendritic Cell Cancer Vaccine Production Sites and Area Served
          • 7.9.2 Dendritic Cell Cancer Vaccine Product Introduction, Application and Specification
          • 7.9.3 Sanpower Corporation (Dendreon) Dendritic Cell Cancer Vaccine Production, Revenue, Price and Gross Margin (2014-2019)
          • 7.9.4 Main Business and Markets Served
        • 7.10 Elios Therapeutics
          • 7.10.1 Elios Therapeutics Dendritic Cell Cancer Vaccine Production Sites and Area Served
          • 7.10.2 Dendritic Cell Cancer Vaccine Product Introduction, Application and Specification
          • 7.10.3 Elios Therapeutics Dendritic Cell Cancer Vaccine Production, Revenue, Price and Gross Margin (2014-2019)
          • 7.10.4 Main Business and Markets Served
        • 7.11 Immunicum
        • 7.12 Kiromic
        • 7.13 Merck
        • 7.14 Northwest Biotherapeutics
        • 7.15 Glaxo Smith Kline
        • 7.16 ImmunoCellular
        • 7.17 Tella
        • 7.18 Vaxil Bio
        • 7.19 Medigene

        8 Dendritic Cell Cancer Vaccine Manufacturing Cost Analysis

        • 8.1 Dendritic Cell Cancer Vaccine Key Raw Materials Analysis
          • 8.1.1 Key Raw Materials
          • 8.1.2 Price Trend of Key Raw Materials
          • 8.1.3 Key Suppliers of Raw Materials
        • 8.2 Proportion of Manufacturing Cost Structure
        • 8.3 Manufacturing Process Analysis of Dendritic Cell Cancer Vaccine
        • 8.4 Dendritic Cell Cancer Vaccine Industrial Chain Analysis

        9 Marketing Channel, Distributors and Customers

        • 9.1 Marketing Channel
          • 9.1.1 Direct Marketing
          • 9.1.2 Indirect Marketing
        • 9.2 Dendritic Cell Cancer Vaccine Distributors List
        • 9.3 Dendritic Cell Cancer Vaccine Customers

        10 Market Dynamics

        • 10.1 Market Trends
        • 10.2 Opportunities
        • 10.3 Market Drivers
        • 10.4 Challenges
        • 10.5 Influence Factors

        11 Global Dendritic Cell Cancer Vaccine Market Forecast

        • 11.1 Global Dendritic Cell Cancer Vaccine Production, Revenue Forecast
          • 11.1.1 Global Dendritic Cell Cancer Vaccine Production Growth Rate Forecast (2019-2025)
          • 11.1.2 Global Dendritic Cell Cancer Vaccine Revenue and Growth Rate Forecast (2019-2025)
          • 11.1.3 Global Dendritic Cell Cancer Vaccine Price and Trend Forecast (2019-2025)
        • 11.2 Global Dendritic Cell Cancer Vaccine Production Forecast by Regions (2019-2025)
          • 11.2.1 North America Dendritic Cell Cancer Vaccine Production, Revenue Forecast (2019-2025)
          • 11.2.2 Europe Dendritic Cell Cancer Vaccine Production, Revenue Forecast (2019-2025)
          • 11.2.3 China Dendritic Cell Cancer Vaccine Production, Revenue Forecast (2019-2025)
          • 11.2.4 Japan Dendritic Cell Cancer Vaccine Production, Revenue Forecast (2019-2025)
        • 11.3 Global Dendritic Cell Cancer Vaccine Consumption Forecast by Regions (2019-2025)
          • 11.3.1 North America Dendritic Cell Cancer Vaccine Consumption Forecast (2019-2025)
          • 11.3.2 Europe Dendritic Cell Cancer Vaccine Consumption Forecast (2019-2025)
          • 11.3.3 China Dendritic Cell Cancer Vaccine Consumption Forecast (2019-2025)
          • 11.3.4 Japan Dendritic Cell Cancer Vaccine Consumption Forecast (2019-2025)
        • 11.4 Global Dendritic Cell Cancer Vaccine Production, Revenue and Price Forecast by Type (2019-2025)
        • 11.5 Global Dendritic Cell Cancer Vaccine Consumption Forecast by Application (2019-2025)

        12 Research Findings and Conclusion

          13 Methodology and Data Source

          • 13.1 Methodology/Research Approach
            • 13.1.1 Research Programs/Design
            • 13.1.2 Market Size Estimation
            • 13.1.3 Market Breakdown and Data Triangulation
          • 13.2 Data Source
            • 13.2.1 Secondary Sources
            • 13.2.2 Primary Sources
          • 13.3 Author List

          Dendritic cells (DCs) refer to rare kind of leukocytes. They have prompted their recent application to therapeutic cancer vaccinations as they are uniquely effective in their ability to present antigens to T cells.

          The global Dendritic Cell Cancer Vaccine market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
          This report focuses on Dendritic Cell Cancer Vaccine volume and value at global level, regional level and company level. From a global perspective, this report represents overall Dendritic Cell Cancer Vaccine market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
          At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

          The following manufacturers are covered:
          Medigene
          Activarti
          Argos Therapeutics
          Batavia Bioservices
          Bellicum Pharmaceuticals
          Creagene
          DanDrit Biotech
          DCPrime
          Sanpower Corporation (Dendreon)
          Elios Therapeutics
          Immunicum
          Kiromic
          Merck
          Northwest Biotherapeutics
          Glaxo Smith Kline
          ImmunoCellular
          Tella
          Vaxil Bio
          Medigene

          Segment by Regions
          North America
          Europe
          China
          Japan

          Segment by Type
          CreaVax
          Sipuleucel-T (Provenge)
          Others

          Segment by Application
          Pediatrics
          Adults



          Summary:
          Dendritic Cell Cancer Vaccine Market Research Report is Dendritic Cell Cancer Vaccine Market Report. Get Dendritic Cell Cancer Vaccine market research reports for Market Research, Analysis, Trends & Statistics. Latest Industry findings, analysis and Market Report on Dendritic Cell Cancer Vaccine . Dendritic Cell Cancer Vaccine Market Report is a syndicated market report to understand, Market Demand, Growth, trends analysis and Factor Influencing market in upcoming years.



          REPORT YOU MIGHT BE INTERESTED